Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potts-shunt for Pediatric Severe Pulmonary Hypertension
NCT06429579Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Apr 2024
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Incidence rates of death or Lung Transplantation at 3 years. Started Apr 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06429579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429579.